Online: 24 August 2021 (14:11:16 CEST)
This paper discusses the bioethics of intellectual property (IP) and intellectual property rights (IPR) applicable to biotechnology-based IP. It outlines some of the laws that are related to IPR in Zimbabwe and globally. The paper additionally highlights gaps, opportunities and concerns with the laws. Finally, the paper highlights some initiatives already underway in Zimbabwe targeted at promoting entrepreneurship, commercialization and industrialization while proposing strategies that can be used to further promote the generation and granting of biotechnology-related IP and IPR in Zimbabwe.
REVIEW | doi:10.20944/preprints202002.0017.v1
Online: 3 February 2020 (05:37:23 CET)
Synthetic biology (SynBio) is an interdisciplinary field that has developed rapidly in the last two decades. It involves the design and construction of new biological systems and processes from standardized biological components, networks and synthetic pathways. The goal of Synbio is to create logical forms of cellular control. Biological systems and their parts can be re-designed to carry out completely new functions. SynBio is poised to greatly impact human health, environment, biofuels and chemical production with huge economic benefits. SynBio presents opportunities for the highly agro-based African economies to overcome setbacks that threaten food security: The setbacks are brought about by climate change, land degradation, over-reliance on food imports, global competition, and water and energy security issues among others. With appropriate regulatory frameworks and systems in place, the benefits of harnessing SynBio to boost development in African economies by far potentially outweigh the risks. Countries that are already using GMOs such as South Africa and Kenya should find the application of SynBio seamless, as it would be a matter of expanding the already existing regulations and policies for GMO use.